Product Images Benztropine Mesylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Benztropine Mesylate NDC 11534-169 by Sunrise Pharmaceutical, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
c1789516-figure-01 - c1789516 figure 01
c1789516-figure-02 - c1789516 figure 02
This text provides information about Benztropine Mesylate Tablets, USP with a strength of 0.5 mg in a package containing 100 tablets. It includes details on the usual adult dosage for parkinsonism and drug-induced extrapyramidal disorders. The brand is manufactured and distributed by Sunrise Pharmaceutical, Inc. located in Rahway, NJ. It also gives instructions on storing the medication and keeping it out of children's reach. The NDC number for identification is 11534-167-09.*
c1789516-figure-03 - c1789516 figure 03
This text provides information about a medication called Benztropine Mesylate. Each tablet contains 1mg of the active ingredient. The typical adult dosage for parkinsonism is 1 to 2 mg daily, while for drug-induced extrapyramidal disorders, it is 1 to 4 mg once or twice a day. The tablets should be kept out of reach of children and stored in a well-closed container at 20° to 25°C. The medication is manufactured and distributed by Sunrise Pharmaceutical, Inc.*
c1789516-figure-04 - c1789516 figure 04
This text provides information about a medication containing Benztropine Mesylate, with a usual adult dosage for parkinsonism and drug-induced extrapyramidal disorders. It also mentions instructions for storage and dissemination. The medication is in tablet form and is manufactured and distributed by Sunrise Pharmaceutical, Inc.*
c1789516-figure-05 - c1789516 figure 05
This text contains information about Benztropine Mesylate tablets, which are used for parkinsonism and drug-induced extrapyramidal disorders. The recommended dosage ranges from 1 to 4 mg daily. It emphasizes keeping the drug out of reach of children and storing it in a closed container between 20°C to 25°C. The tablets are manufactured and distributed by Sunrise Pharmaceutical, Inc. in Rahway, NJ.*
c1789516-figure-06 - c1789516 figure 06
This text contains information about Benztropine Mesylate tablets, USP. It provides details on dosage for parkinsonism and drug-induced extrapyramidal disorders. The medication should be kept out of reach of children and stored in a well-closed container at a temperature between 20° to 25°C. The tablets are manufactured and distributed by Sunrise Pharmaceutical, Inc.*
c1789516-figure-07 - c1789516 figure 07
This text provides important information about Benztropine Mesylate tablets, USP. The tablets come in a pack of 1000 and each tablet contains a certain amount of the active ingredient. The recommended adult dosage for parkinsonism and drug-induced extrapyramidal disorders is detailed here. It also specifies storage instructions and details related to the manufacturer, Sunrise Pharmaceutical, Inc. This drug should be kept out of reach of children and dispensed in a well-closed container.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
